메뉴 건너뛰기




Volumn 124, Issue 1-2, 2007, Pages 35-42

Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor

Author keywords

Antibody; Avidin; Drug delivery; Transferrin; Transferrin receptor

Indexed keywords

CYTOTOXICITY; DRUG DELIVERY; MICROSCOPIC EXAMINATION; ONCOLOGY; TOXIC MATERIALS;

EID: 36048930466     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.08.020     Document Type: Article
Times cited : (28)

References (35)
  • 1
    • 33750008791 scopus 로고    scopus 로고
    • The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer
    • Daniels T.R., Delgado T., Rodriguez J.A., Helguera G., and Penichet M.L. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clinical Immunology 121 2 (2006) 144-158
    • (2006) Clinical Immunology , vol.121 , Issue.2 , pp. 144-158
    • Daniels, T.R.1    Delgado, T.2    Rodriguez, J.A.3    Helguera, G.4    Penichet, M.L.5
  • 3
    • 0022636575 scopus 로고
    • A transferrin receptor antibody represents one signal for the induction of IL 2 production by a human T cell line
    • Manger B., Weiss A., Hardy K.J., and Stobo J.D. A transferrin receptor antibody represents one signal for the induction of IL 2 production by a human T cell line. Journal of Immunology 136 2 (1986) 532-538
    • (1986) Journal of Immunology , vol.136 , Issue.2 , pp. 532-538
    • Manger, B.1    Weiss, A.2    Hardy, K.J.3    Stobo, J.D.4
  • 5
    • 0032959574 scopus 로고    scopus 로고
    • Transferrin receptor is necessary for development of erythrocytes and the nervous system
    • Levy J.E., Jin O., Fujiwara Y., Kuo F., and Andrews N.C. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nature Genetics 21 4 (1999) 396-399
    • (1999) Nature Genetics , vol.21 , Issue.4 , pp. 396-399
    • Levy, J.E.1    Jin, O.2    Fujiwara, Y.3    Kuo, F.4    Andrews, N.C.5
  • 6
    • 33750019824 scopus 로고    scopus 로고
    • The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells
    • Daniels T.R., Delgado T., Helguera G., and Penichet M.L. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clinical Immunology 121 2 (2006) 159-176
    • (2006) Clinical Immunology , vol.121 , Issue.2 , pp. 159-176
    • Daniels, T.R.1    Delgado, T.2    Helguera, G.3    Penichet, M.L.4
  • 7
    • 0141955901 scopus 로고    scopus 로고
    • Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects
    • Lu Y., and Low P.S. Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects. Journal of Controlled Release 91 1-2 (2003) 17-29
    • (2003) Journal of Controlled Release , vol.91 , Issue.1-2 , pp. 17-29
    • Lu, Y.1    Low, P.S.2
  • 8
    • 0025005475 scopus 로고
    • Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects
    • White S., Taetle R., Seligman P.A., Rutherford M., and Trowbridge I.S. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Research 50 19 (1990) 6295-6301
    • (1990) Cancer Research , vol.50 , Issue.19 , pp. 6295-6301
    • White, S.1    Taetle, R.2    Seligman, P.A.3    Rutherford, M.4    Trowbridge, I.S.5
  • 9
    • 0031451777 scopus 로고    scopus 로고
    • Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors
    • Laske D.W., Youle R.J., and Oldfield E.H. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nature Medicine 3 12 (1997) 1362-1368
    • (1997) Nature Medicine , vol.3 , Issue.12 , pp. 1362-1368
    • Laske, D.W.1    Youle, R.J.2    Oldfield, E.H.3
  • 10
    • 0344876636 scopus 로고    scopus 로고
    • Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas
    • Weaver M., and Laske D.W. Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. Journal of Neuro-oncology 65 1 (2003) 3-13
    • (2003) Journal of Neuro-oncology , vol.65 , Issue.1 , pp. 3-13
    • Weaver, M.1    Laske, D.W.2
  • 13
    • 33646137581 scopus 로고    scopus 로고
    • Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes
    • Chiu S.J., Liu S., Perrotti D., Marcucci G., and Lee R.J. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. Journal of Controlled Release 112 2 (2006) 199-207
    • (2006) Journal of Controlled Release , vol.112 , Issue.2 , pp. 199-207
    • Chiu, S.J.1    Liu, S.2    Perrotti, D.3    Marcucci, G.4    Lee, R.J.5
  • 15
    • 36049031656 scopus 로고    scopus 로고
    • G.L. Mayers, J. Razeq, M.M. Abu-Hadid, Cytotoxic drug conjugates for treatment of neoplastic disease. US Patent Application No. 5,393,737. (1995).
  • 17
    • 0025288944 scopus 로고
    • Avidin and streptavidin
    • Green N.M. Avidin and streptavidin. Methods in Enzymology 184 (1990) 51-67
    • (1990) Methods in Enzymology , vol.184 , pp. 51-67
    • Green, N.M.1
  • 18
    • 33750631022 scopus 로고    scopus 로고
    • Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor
    • Ng P.P., Helguera G., Daniels T.R., Lomas S.Z., Rodriguez J.A., Schiller G., Bonavida B., Morrison S.L., and Penichet M.L. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. Blood 108 8 (2006) 2745-2754
    • (2006) Blood , vol.108 , Issue.8 , pp. 2745-2754
    • Ng, P.P.1    Helguera, G.2    Daniels, T.R.3    Lomas, S.Z.4    Rodriguez, J.A.5    Schiller, G.6    Bonavida, B.7    Morrison, S.L.8    Penichet, M.L.9
  • 19
    • 0023243675 scopus 로고
    • Functional expression of the human transferrin receptor cDNA in Chinese hamster ovary cells deficient in endogenous transferrin receptor
    • McGraw T.E., Greenfield L., and Maxfield F.R. Functional expression of the human transferrin receptor cDNA in Chinese hamster ovary cells deficient in endogenous transferrin receptor. The Journal of Cell Biology 105 1 (1987) 207-214
    • (1987) The Journal of Cell Biology , vol.105 , Issue.1 , pp. 207-214
    • McGraw, T.E.1    Greenfield, L.2    Maxfield, F.R.3
  • 21
    • 0019129529 scopus 로고
    • Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens
    • Suter L., Bruggen J., and Sorg C. Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens. Journal of Immunological Methods 39 4 (1980) 407-411
    • (1980) Journal of Immunological Methods , vol.39 , Issue.4 , pp. 407-411
    • Suter, L.1    Bruggen, J.2    Sorg, C.3
  • 23
    • 27144550160 scopus 로고    scopus 로고
    • Arming antibodies: prospects and challenges for immunoconjugates
    • Wu A.M., and Senter P.D. Arming antibodies: prospects and challenges for immunoconjugates. Nature Biotechnology 23 9 (2005) 1137-1146
    • (2005) Nature Biotechnology , vol.23 , Issue.9 , pp. 1137-1146
    • Wu, A.M.1    Senter, P.D.2
  • 25
    • 0037064136 scopus 로고    scopus 로고
    • Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor alpha protease inhibitor-2
    • Kaup M., Dassler K., Weise C., and Fuchs H. Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor alpha protease inhibitor-2. The Journal of Biological Chemistry 277 41 (2002) 38494-38502
    • (2002) The Journal of Biological Chemistry , vol.277 , Issue.41 , pp. 38494-38502
    • Kaup, M.1    Dassler, K.2    Weise, C.3    Fuchs, H.4
  • 26
    • 0034864020 scopus 로고    scopus 로고
    • Phase I and II clinical trials of trastuzumab
    • Baselga J. Phase I and II clinical trials of trastuzumab. Annals of Oncology 12 Suppl 1 (2001) S49-S55
    • (2001) Annals of Oncology , vol.12 , Issue.SUPPL. 1
    • Baselga, J.1
  • 31
    • 1642535523 scopus 로고    scopus 로고
    • Reducing the immune response to immunotoxin
    • Frankel A.E. Reducing the immune response to immunotoxin. Clinical Cancer Research 10 1 Pt 1 (2004) 13-15
    • (2004) Clinical Cancer Research , vol.10 , Issue.1 PART 1 , pp. 13-15
    • Frankel, A.E.1
  • 32
    • 0023942583 scopus 로고
    • Killing of K562 cells with conjugates between human transferrin and a ribosome-inactivating protein (SO-6)
    • Bergamaschi G., Cazzola M., Dezza L., Savino E., Consonni L., and Lappi D. Killing of K562 cells with conjugates between human transferrin and a ribosome-inactivating protein (SO-6). British Journal of Haematology 68 3 (1988) 379-384
    • (1988) British Journal of Haematology , vol.68 , Issue.3 , pp. 379-384
    • Bergamaschi, G.1    Cazzola, M.2    Dezza, L.3    Savino, E.4    Consonni, L.5    Lappi, D.6
  • 34
    • 3843131713 scopus 로고    scopus 로고
    • Design and engineering of human forms of monoclonal antibodies
    • Penichet M.L., and Morrison S.L. Design and engineering of human forms of monoclonal antibodies. Drug Development Research 61 3 (2004) 121-136
    • (2004) Drug Development Research , vol.61 , Issue.3 , pp. 121-136
    • Penichet, M.L.1    Morrison, S.L.2
  • 35
    • 0034331218 scopus 로고    scopus 로고
    • Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
    • Brossart P., Wirths S., Stuhler G., Reichardt V.L., Kanz L., and Brugger W. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96 9 (2000) 3102-3108
    • (2000) Blood , vol.96 , Issue.9 , pp. 3102-3108
    • Brossart, P.1    Wirths, S.2    Stuhler, G.3    Reichardt, V.L.4    Kanz, L.5    Brugger, W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.